ArticleMolecular biology reports2026
Eurycomanone from Eurycoma longifolia Jack roots regulates dopamine secretion via transsynaptic GABA signalling in differentiated SH-SY5Y human neuroblastoma cells: a transcriptomic study.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeEurycomanone (EN), a quassinoid from Eurycoma longifolia Jack (EL) has been previously shown to promote dopamine secretion from differentiated SH-SY5Y human neuroblastoma cells but the mechanism that underpins this property is unknown. This study sought to investigate transcriptomic changes associated with the dopamine secretory property of the isolated EN in the differentiated SH-SY5Y cells.
methodsDifferential gene expression (DGE) in EN-responsive SH-SY5Y cells was investigated by microarray analysis.
resultsPrevious work demonstrated that EN stimulated dopamine secretion in a dose-dependent manner at 5, 10 and 15 µM, followed by reduction in secretion at higher concentration (20 to 25 µM). At 15 µM, EN significantly increased dopamine secretion compared to the positive control, clorgyline hydrochloride (10 µM, p < 0.05). Microarray analysis showed that gene expression changes by EN and the bioactive fraction Fr2 across varying concentrations closely corresponded to the observed dopamine secretion profiles. Accordingly, 15 µM EN, which elicited the most pronounced differential gene expression (DGE) was selected for pathway enrichment analysis. Subsequent qPCR validation suggested that EN modulates transsynaptic signalling between GABA-producing and differentiated SH-SY5Y cells. In silico molecular docking study further indicated that EN may activate cannabinoid CB1 and muscarinic M3 receptors, potentially suppressing inhibitory GABA release and thereby facilitating dopamine secretion in differentiated cells. The resultant increase in dopaminergic excitability by EN may be counter-regulated through AMPK-dependent autophagy.
conclusionThese transcriptomic findings support a neurobiochemical role of EN in promoting dopaminergic activity, offering a mechanistic basic for the traditional use of EL roots as a male sexual booster.
Indexed as
Identifiers
41746440What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.